Andrew S. Boyer, Executive VP, Comm Optns at Amneal Pharmaceuticals, Inc. (AMRX), bought 38,000 shares at $9.46 ($359K) on 2019-05-13, disclosed to the SEC on 2019-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.46 | 19,000 | $180K | 50.0% |
| 2 | $9.46 | 19,000 | $180K | 50.0% |
| Total | $9.46 avg | 38,000 | $359K | 100% |
| Filing → |
| AMRX | SELL | 2025-03-07 | $1.1M | — | Filing → |
| AMRX | SELL | 2024-08-16 | $983K | — | Filing → |
| AMRX | SELL | 2023-08-15 | $242K | — | Filing → |